FGF19 and myasthenia gravis: In vitro experiments demonstrated that FGF-19 promotes B-cell to plasma cell differentiation in MG patients.<h4>Interpretation</h4>EFG treatment can alleviate the clinical symptoms and decrease IgG levels in patients with MG.